125 related articles for article (PubMed ID: 18289057)
1. Experimental models for the study of drugs used to prevent and treat vascular diseases.
Paraskevas KI; Mikhailidis DP; Thompson CS
Curr Pharm Des; 2008; 14(4):306-8. PubMed ID: 18289057
[No Abstract] [Full Text] [Related]
2. Statins and renal function.
Elisaf M; Mikhailidis DP
Angiology; 2002; 53(5):493-502. PubMed ID: 12365855
[TBL] [Abstract][Full Text] [Related]
3. Vascular pharmacotherapy and dementia.
Piguet O; Garner B
Curr Vasc Pharmacol; 2010 Jan; 8(1):44-50. PubMed ID: 19485934
[TBL] [Abstract][Full Text] [Related]
4. [Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].
Alhadad A; Wiktorsson C; Lindblad B; Gottsäter A
Lakartidningen; 2010 Sep 29-Oct 5; 107(39):2322-5. PubMed ID: 20973248
[No Abstract] [Full Text] [Related]
5. Pharmacologic therapy for peripheral arterial disease and claudication.
Hiatt WR
J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
[TBL] [Abstract][Full Text] [Related]
6. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
Paraskevas KI
J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
[No Abstract] [Full Text] [Related]
7. Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys.
Lentz SR; Piegors DJ; Malinow MR; Heistad DD
Circulation; 2001 Feb; 103(7):1006-11. PubMed ID: 11181477
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis: a promising treatment option for peripheral arterial disease.
Paraskevas KI; Mikhailidis DP
Curr Vasc Pharmacol; 2008 Apr; 6(2):78-80. PubMed ID: 18393907
[No Abstract] [Full Text] [Related]
9. Peripheral vascular disease.
Iannone LA; Rayl KL
Iowa Med; 1992 Jun; 82(6):261-2. PubMed ID: 1618620
[No Abstract] [Full Text] [Related]
10. Atherosclerotic renal artery stenosis: update on management strategies.
Meier P
Curr Opin Cardiol; 2011 Nov; 26(6):463-71. PubMed ID: 21799405
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic angiogenesis.
Mishra NK; Sinha RS; Malhotra S; Gupta B; Tripathi BK
J Assoc Physicians India; 2000 Sep; 48(9):913-5. PubMed ID: 11198793
[No Abstract] [Full Text] [Related]
12. Pulmonary vascular disease: our need to understand.
Barst RJ
Chest; 1998 Jul; 114(1):8-9. PubMed ID: 9674439
[No Abstract] [Full Text] [Related]
13. [Effect of cholestyramine on angiopathies in cholesterol-fed mice and diabetic mice].
Sugiura M; Suenaga H; Kasuya Y; Kamata K
J Smooth Muscle Res; 1995 Dec; 31(6):400-2. PubMed ID: 8867947
[No Abstract] [Full Text] [Related]
14. The importance of conservative measures in peripheral arterial disease: an update.
Paraskevas KI; Papas TT; Pavlidis P; Bessias N; Andrikopoulos V
Angiology; 2008; 59(5):529-33. PubMed ID: 18504264
[No Abstract] [Full Text] [Related]
15. [Stroke in chronic renal failure].
Bereczki D
Orv Hetil; 2008 Apr; 149(15):691-6. PubMed ID: 18387873
[TBL] [Abstract][Full Text] [Related]
16. Peripheral vascular disease improved by clofibrate.
Exp Med Surg; 1968; 26(4):277-9. PubMed ID: 5736504
[No Abstract] [Full Text] [Related]
17. Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease.
Chade AR; Williams ML; Guise E; Vincent LJ; Harvey TW; Kuna M; Mahdi F; Bidwell GL
Kidney Int; 2018 Apr; 93(4):842-854. PubMed ID: 29273331
[TBL] [Abstract][Full Text] [Related]
18. Drugs used to lower high lipid levels.
Hopkins SJ
Nurs Stand; 1994 Nov 2-8; 9(6):27-9. PubMed ID: 7811617
[TBL] [Abstract][Full Text] [Related]
19. Assessment and management of vascular disease risk in patients with chronic kidney disease.
Brown WV; Bakris G; Lerma E; Chertow G
J Clin Lipidol; 2011; 5(4):251-60. PubMed ID: 21784369
[No Abstract] [Full Text] [Related]
20. [Vascular risk factors].
Renou P
Presse Med; 2002 Oct; 31(34):1624-8. PubMed ID: 12426981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
